TIL · Instil Bio, Inc.
The latest filing states the doubt was alleviated.
“As discussed above and in Note 8 to the accompanying condensed consolidated financial statements, the 2024 Loan is due in January 2027, for total principal of $85.6 million, which is in excess of cash, cash equivalents, and marketable securities on hand as of March 31, 2026, which we concluded is an indicator of substantial doubt about our ability to continue as a going concern. We concluded that management's plans, including Complex Therapeutics LLC's contractual right to exercise the extension option to January 2028, which is within Complex Therapeutics LLC's control, alleviate the conditions that raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-11 | Gibson Neil W |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
0 |
| 2026-06-11 | Binder Gwendolyn |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2026-06-11 | Matcham George |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2026-06-11 | McGaughy R Kent Jr |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2025-09-10 | Laumas Sandeep |
CFO and CBO |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2). |
Common Stock
|
12,461 |
| 2025-09-10 | Laumas Sandeep |
CFO and CBO |
Convert↑
|
Common Stock
|
13,000 |
| 2025-09-10 | Laumas Sandeep |
CFO and CBO |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter. |
Employee Stock Option (right to buy)
|
17,000 |
| 2025-09-10 | Laumas Sandeep |
CFO and CBO |
Convert↑
|
Common Stock
|
17,000 |
| 2025-09-10 | Laumas Sandeep |
CFO and CBO |
Convert↓
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter. |
Employee Stock Option (right to buy)
|
13,000 |
| 2025-09-10 | Laumas Sandeep |
CFO and CBO |
Sell↓
Filing footnotes — Common Stock (Direct)
The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1). |
Common Stock
|
17,539 |
| 2025-05-28 | Matcham George |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2025-05-28 | Binder Gwendolyn |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2025-05-28 | Gibson Neil W |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2025-05-28 | McGaughy R Kent Jr |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on June 28, 2025, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
6,500 |
| 2025-04-25 | Laumas Sandeep |
CFO and CBO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
44,851 |
| 2025-04-25 | Crouch Bronson |
Director, CEO and Chairman, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
105,157 |
| 2024-09-18 | Laumas Sandeep |
CFO and CBO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
45,000 |
| 2024-09-18 | Crouch Bronson |
Director, CEO and Chairman, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
50,000 |
| 2024-06-13 | Gibson Neil W |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
5,000 |
| 2024-06-13 | Binder Gwendolyn |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
5,000 |
| 2024-06-13 | McGaughy R Kent Jr |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
5,000 |
| 2024-06-13 | Matcham George |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 substantially equal monthly installments commencing on July 13, 2024, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan). |
Stock Option (Right to Buy)
|
5,000 |
| 2024-02-10 | Crouch Bronson |
Director, CEO and Chairman, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
120,000 |
| 2024-02-10 | Laumas Sandeep |
CFO and CBO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
80,000 |
| 2023-06-14 | McGaughy R Kent Jr |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-06-14 | Binder Gwendolyn |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-06-14 | Matcham George |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-06-14 | Gibson Neil W |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-06-14 | Nielsen Jack |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option will vest in 12 equal monthly installments commencing on July 14, 2023, subject to the Report Person's continued service as a director through the vesting date. |
Stock Option (Right to Buy)
|
1,500 |
| 2023-01-18 | Ray Sumita |
Chief Legal and Admin Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on January 18, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
50,000 |
| 2023-01-08 | Crouch Bronson |
Director, CEO and Chairman, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
1,000,000 |
| 2023-01-08 | Laumas Sandeep |
CFO and CBO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
415,000 |
| 2023-01-08 | Ray Sumita |
Chief Legal and Admin Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
415,000 |
| 2022-09-06 | MOORE TIMOTHY L. |
Chief Technical Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on September 6, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
750,000 |
| 2022-09-06 | MOORE TIMOTHY L. |
Chief Technical Officer |
Other↑
|
No Securities Owned
|
0 |
| 2022-05-20 | Binder Gwendolyn |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date. |
Employee Stock Option (right to buy)
|
30,000 |
| 2022-05-20 | McGaughy R Kent Jr |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date. |
Employee Stock Option (right to buy)
|
30,000 |
| 2022-05-20 | Matcham George |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date. |
Employee Stock Option (right to buy)
|
30,000 |
| 2022-05-20 | Nielsen Jack |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date. |
Employee Stock Option (right to buy)
|
30,000 |
| 2022-05-20 | Chiruvolu Vijay |
Chief Technical Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on May 20, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
154,237 |
| 2022-05-20 | Gibson Neil W |
Director |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option will vest in 12 equal monthly installments commencing on June 20, 2022, subject to the Report Person's continued service as a director through the vesting date. |
Employee Stock Option (right to buy)
|
30,000 |
| 2022-03-15 | McGaughy R Kent Jr |
Director |
Other↓
Filing footnotes — Common Stock (Indirect)
The LP distributed these shares to its partners on a pro rata basis, for no consideration. The securities are held by Ibisbill, LP (the "LP"). CPMG, Inc. is the general partner of the LP and has voting and investment control over the shares beneficially owned by the LP. The Reporting Person is the sole shareholder and managing director of CPMG, Inc. and may be deemed to share voting and investment power with respect to the shares beneficially owned by the LP. The Reporting Person disclaims beneficial ownership of the shares beneficially owned by LP except to the extent of any pecuniary interest therein. |
Common Stock
(I)
|
260,323 |
| 2022-03-04 | Laumas Sandeep |
CFO and CBO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
234,000 |
| 2022-03-04 | Chiruvolu Vijay |
Chief Technical Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
257,000 |
| 2022-03-04 | Roberts Zachary |
EVP of R&D |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
245,000 |
| 2022-03-04 | Crouch Bronson |
Director, CEO and Chairman, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
750,000 |
| 2021-10-07 | Roberts Zachary |
EVP of R&D |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on October 7, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock. |
Employee Stock Option (right to buy)
|
120,000 |
| 2021-09-10 | Roberts Zachary |
EVP of R&D |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
Represents performance-based stock option previously granted to the Reporting Person by the Issuer on May 9, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Issuer's Compensation Committee on September 10, 2021, resulting in the immediate vesting of the stock option as to 120,000 shares of Common Stock. |
Employee Stock Option (right to buy)
|
120,000 |
| 2021-05-11 | Laumas Sandeep |
CFO and CBO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
200,000 |
| 2021-05-11 | Chiruvolu Vijay |
Chief Technical Officer |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date. |
Employee Stock Option (right to buy)
|
200,000 |